In conclusion, our findings not only further verified the potential of PAI-1 as a therapeutic target of metastatic ESCC, but also characterized a functional antibody that inhibits metastasis of ESCC in vitro and in vivo. The gene discussed is SERPINE1; the disease is esophageal squamous cell carcinoma.